期刊文献+

来氟米特联合小剂量泼尼松对难治性肾病综合征患者肾功能及血清肌酐尿素氮水平的影响 被引量:3

Effects of leflunomide combined with low-dose prednisone on renal function and serum Scr and BUN levels in patients with refractory nephrotic syndrome
下载PDF
导出
摘要 目的 探讨来氟米特联合小剂量泼尼松对难治性肾病综合征患者肾功能及血清肌酐、尿素氮水平的影响.方法 将92例难治性肾病综合征患者根据治疗方案分为两组各46例,观察组口服来氟米特联合小剂量泼尼松治疗,对照组口服环磷酰胺联合足量泼尼松治疗,观察6个月.治疗前后检测分析两组血清肌酐、尿素氮水平的变化,随时记录治疗过程中出现的不良反应.结果 治疗前两组血清肌酐、尿素氮水平比较差异无统计学意义(P〉0.05),治疗后两组血清肌酐、尿素氮水平均较治疗前显著下降,且观察组显著低于对照组(P〈0.01);观察组不良反应发生率(6.5%)显著低于对照组(21.7%)(P〈0.05).结论 来氟米特联合小剂量泼尼松治疗难治性肾病综合征,能有效降低患者血清肌酐、尿素氮水平,改善肾功能,且高安全性,值得在临床推广应用. Objective To investigate the effect of leflunomide combined with low-dose prednisone on renal function and serum creatinine (Scr) and urea nitrogen (BUN) levels in patients with refractory nephrotic syndrome (NS). Methods Ninety-two patients hospitalized in our hospital were selected as research ob jects and assigned to observation group and control group of 46 ones each according to therapeutic regimen. Observation group received leflunomide combined with low-dose prednisone, control group received cyclophosphamide combined with adequate prednisone. Patients were observed for 6 months. The changes of serum Ser and BUN levels of the two groups before and after treatment were detected and analyzed. Ad erse reactions during process of the treatment were recorded at any time. Results There were no signifi cant differences in Scr and BUN levels between the two groups before treatment (P〉0.05), the Scr and BUN levels in the two groups were decreased after treatment, and the observation group was lower than those in the control group, the difference was statistic significant (P〈0.05); The incidence of adverse re actions in the observation group (6.5%) was lower than that in the control group (21.7%), the difference was statistic significant (P〈0.05). Conclusion The treatment of refractory nephrotic syndrome using leflunomide combined with low-dose prednisone can effectively reduce the serum Scr and BUN levels, im prove renal function, it has higher safety and is worthy of clinic application.
作者 陈长生 Chen Changsheng(Zhengzhou Yihe Hospital, Zhengzhou 450047, Henan , Chin)
机构地区 郑州颐和医院
出处 《临床心身疾病杂志》 CAS 2017年第5期28-30,共3页 Journal of Clinical Psychosomatic Diseases
关键词 难治性肾病综合征 来氟米特 小剂量泼尼松 肾功能 血清肌酐 尿素氮 Refractory nephrotic syndrome Leflunomide Low-dose prednisone Renal function Scr:BUN
  • 相关文献

参考文献6

二级参考文献67

  • 1暨利军.难治性肾病综合征的治疗进展[J].临床荟萃,1996,11(18):819-820. 被引量:5
  • 2曹励欧,倪兆慧,钱家麒,林爱武,张伟明,方炜,朱铭力,王琴,牟姗,严玉澄.来氟米特对Ⅳ型及Ⅴ型狼疮肾炎的诱导维持治疗[J].中华肾脏病杂志,2007,23(1):3-7. 被引量:20
  • 3姚上志,胡敏涛,张波,周红燕.异甘草酸镁治疗肾综合征出血热疗效观察[J].中国微循环,2007,11(5):341-341. 被引量:8
  • 4孙晓红,李保华.四联疗法治疗难治性肾病综合征及对患者血清IL-6、TNF-α的影响[J].新疆医科大学学报,2007,30(9):972-974. 被引量:7
  • 5王海燕,郑法雷,刘玉春,等.原发性肾小球疾病分型与治疗及诊断标准专题座谈会纪要[J].中华内科杂志,1993,32(2):131-134.
  • 6Toshiharu Ninomiya,Vlado Perkovic,Christine Verdon,Federica Barzi,Alan Cass,Martin Gallagher,Meg Jardine,Craig Anderson,John Chalmers,Jonathan C. Craig,Rachel Huxley.Proteinuria and Stroke: A Meta-analysis of Cohort Studies[J]. American Journal of Kidney Diseases . 2009 (3)
  • 7McClure MT,Stupans I.Investigation of the mechanism by which cyclophosphamide alters cytochrome P450 in male rats [ J ].Biochem Pharmacol,1992,43(12):2 655-2 658.
  • 8Ahn YH, Kang HG, Kim SH, et al. Efficacy and Safety of Rituximab in Children with Refractory Nephrotic Syndrome; A Multicenter Clinical Trial[J]. Kidney Research and Clinical Practice,2014,33 (2):A1- A2.
  • 9Kyrieleis HA, Lowik MM, Pronk 1, et at. Long-term outcome of biopsy-proven, frequently relapsing minimalchange nephrotic syndrome in children[J]. Clin J Am Soc Nephrol , 2009,4(0) : 1593-1600.
  • 10Lennon R, Watson L, Webb NJ. Nephrotic syndreome in children[J]. Paediatr Child Health,2012,20(l) :36-42.

共引文献74

同被引文献34

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部